Self‐Assembled Aptamer‐Based Drug Carriers for Bispecific Cytotoxicity to Cancer Cells
- 11 April 2012
- journal article
- research article
- Published by Wiley in Chemistry – An Asian Journal
- Vol. 7 (7), 1630-1636
- https://doi.org/10.1002/asia.201101060
Abstract
Monovalent aptamers can deliver drugs to target cells by specific recognition. However, different cancer subtypes are distinguished by heterogeneous biomarkers and one single aptamer is unable to recognize all clinical samples from different patients with even the same type of cancers. To address heterogeneity among cancer subtypes for targeted drug delivery, as a model, we developed a drug carrier with a broader recognition range of cancer subtypes. This carrier, sgc8c‐sgd5a (SD), was self‐assembled from two modified monovalent aptamers. It showed bispecific recognition abilities to target cells in cell mixtures; thus broadening the recognition capabilities of its parent aptamers. The self‐assembly of SD simultaneously formed multiple drug loading sites for the anticancer drug doxorubicin (Dox). The Dox‐loaded SD (SD–Dox) also showed bispecific abilities for target cell binding and drug delivery. Most importantly, SD–Dox induced bispecific cytotoxicity in target cells in cell mixtures. Therefore, by broadening the otherwise limited recognition capabilities of monovalent aptamers, bispecific aptamer‐based drug carriers would facilitate aptamer applications for clinically heterogeneous cancer subtypes that respond to the same cancer therapy.Keywords
Funding Information
- NIH (GM066137, CA133086)
This publication has 42 references indexed in Scilit:
- Single-cell dissection of transcriptional heterogeneity in human colon tumorsNature Biotechnology, 2011
- Engineering Polymeric Aptamers for Selective CytotoxicityJournal of the American Chemical Society, 2011
- Bi-specific Aptamers Mediating Tumor Cell LysisOnline Journal of Public Health Informatics, 2011
- A multivalent DNA aptamer specific for the B-cell receptor on human lymphoma and leukemiaNucleic Acids Research, 2010
- Self-assembling chimeric polypeptide–doxorubicin conjugate nanoparticles that abolish tumours after a single injectionNature Materials, 2009
- Aptamers Generated from Cell-SELEX for Molecular Medicine: A Chemical Biology ApproachAccounts of Chemical Research, 2009
- Molecular Assembly of an Aptamer–Drug Conjugate for Targeted Drug Delivery to Tumor CellsChemBioChem, 2009
- Molecular recognition of acute myeloid leukemia using aptamersLeukemia, 2009
- Molecular assembly for high-performance bivalent nucleic acid inhibitorProceedings of the National Academy of Sciences of the United States of America, 2008
- Aptamers evolved from live cells as effective molecular probes for cancer studyProceedings of the National Academy of Sciences of the United States of America, 2006